Diagnostic Accuracy of Teledermatology in Patch Test Interpretation (Tele patch)

November 24, 2024 updated by: Silada Kanokrungsee, Mahidol University

The goal of this clinical trial is to learn about accuracy of teledermatology in patch test interpretation in patch test's patients population. The main question[s] it aims to answer are:

  • Accuracy of teledermatology in patch test interpretation by dermatologist
  • Accuracy of teledermatology in patch test interpretation by Residency
  • Accuracy of teledermatology in patch test interpretation by Scitentist
  • The factors influencing the interpretation of remote dermatologic patch test results from photographs of patients.

Participants will

  • do patch test in Siriraj hospital and come to follow up at 48 hr and 72 hr for interpretation of patch test
  • take a photo at home and sent the photo to contact clinic via online application or email on the day of 48 hr, 72 hr and 7 days following the interpretation of patch test

Researchers will compare in-clinic group and telephoto group to see if the accuracy of patch test interpretation is more or less.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Thailand
    • Bangkok
      • Bangkoknoi, Bangkok, Thailand, 10700
        • Faculty of Medicine, Siriraj Hospital, Mahidol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants in the study must be 18 years of age or older.
  • Participants in the study must have undergone patch testing for contact allergies.
  • Participants in the study should be able to take photos of test results on their back and/or arms using a mobile phone or personal camera, and send them to the researcher through the Line application and/or email within 48 hours, 96 hours, and on the 7th day.
  • Participants in the study should be able to read and comprehend the questionnaire in Thai and respond to the questionnaire independently.
  • Participants in the study must have at least one positive result in the patch testing.
  • Participants in the study must provide consent to participate in the study by signing the informed consent document.

Exclusion Criteria:

  • Participants in the study who are unable to attend follow-up appointments for result assessments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: In-Clinic interpretation
After doing patch test, patient come to Siriraj hospital to interpret the results at 48 hr and 72 hr.
Diagnostic test: In-clinic interpretation
Reading patch test result at clinic
Diagnostic test: Photo interpretation
Reading patch test result by sending photo to clinic
Experimental: Photo interpretation
After doing patch test, patient take a photo to Siriraj hospital by LINE application to interpret the results at 48 hr, 72 hr and 7 days
Diagnostic test: In-clinic interpretation
Reading patch test result at clinic
Diagnostic test: Photo interpretation
Reading patch test result by sending photo to clinic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
grading of patch test
Time Frame: 48 hours, 72 hours and 7 days
sucess, intermediate and failure
48 hours, 72 hours and 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mahidol University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2024

Primary Completion (Actual)

September 2, 2024

Study Completion (Actual)

November 24, 2024

Study Registration Dates

First Submitted

January 10, 2024

First Submitted That Met QC Criteria

January 18, 2024

First Posted (Actual)

January 19, 2024

Study Record Updates

Last Update Posted (Estimated)

November 27, 2024

Last Update Submitted That Met QC Criteria

November 24, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • COA 694/2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Prohibited from laws (and/or rules,regulations,contracts), Fear of inappropriate use of data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Teledermatology

Clinical Trials on In-clinic interpretation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe